½ÃÀ庸°í¼­
»óǰÄÚµå
1679580

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­(2025-2030³â) : Á¦Ç°º°, ¿¬°á ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø

Image-guided Therapy Systems Market Size, Share & Trends Analysis Report By Product (Endoscope, MRI, X-ray Fluoroscopy), By Connectivity Technology (Cardiac Surgery, Neurosurgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025-2030³â¿¡ °ÉÃÄ CAGR 5.2%¸¦ ±â·ÏÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 69¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. ³ëÀÎ Áõ°¡¿Í ¸¸¼º Áúȯ ȯÀÚ Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ê¾÷ÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ¾Ï ¹æ»ç¼± Ä¡·áÀÇ ºÎ¹®¿¡¼­ ÀÌ·ç¾îÁö°í ÀÖ´Â ´Ù¾çÇÑ ÀÌ´Ï¼ÅÆ¼ºê°¡ »ê¾÷À» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

´ë±â¾÷ÀÇ ½ÅÁ¦Ç° Ãâ½Ãµµ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 9¿ù Olympus CorporationÀº ¼ÒÈ­°ü¿ë ÄÄÇ»ÅÍ °¨Áö ±â´ÉÀ» °®Ãá AI Ç÷§Æû°ú ³»½Ã°æ ¾ÖÇø®ÄÉÀÌ¼Ç 'ENDO-AID'¸¦ Ãâ½ÃÇß½À´Ï´Ù. ³»½Ã°æ ½Ã½ºÅÛ-EVIS X1ÀÌ ÀåÂøµÈ AI Ç÷§ÆûÀº ½Ç½Ã°£ µð½ºÇ÷¹À̸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ½Ã½ºÅÛÀÇ Ã¤¿ë È®´ë°¡ »ê¾÷À» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¾Ï ¹æ»ç¼± Ä¡·áÀÇ ºÎ¹®¿¡¼­ ¹Î°£ ±â¾÷ ¹× °ø°ø±â°ü¿¡ ÀÇÇÑ ÀÌ´Ï¼ÅÆ¼ºê°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ »ê¾÷ÀÇ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ¸¹Àº Çмú±â°üµéÀÌ Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇØ ¾Ï ¹æ»ç¼± Ä¡·á ÇÁ·ÎÁ§Æ®¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç ÀÌ ¶ÇÇÑ ½ÃÀå È®´ë¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀÇ ¿¹·Î´Â Brigham and Women's Hospital°¡ ÁÖµµÇÏ´Â ¿µ»ó À¯µµ Ä¡·á ÇÁ·Î±×·¥ÀÇ °³¹ßÀ» µé ¼ö ÀÖÀ¸¸ç ÇØ´ç ÇÁ·Î±×·¥Àº Àúħ½À ¼ö¼ú°ú ÀÎÅͺ¥¼Ç ±â¼úÀ» °³¹ßÇϱâ À§ÇÑ ¿µ»ó ±â¼ú°ú Ä¡·á ±â¼úÀÇ Çâ»óÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ³»½Ã°æ ºÎ¹®Àº ¼¼°èÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ »ê¾÷À» ÁÖµµÇϰí ÀÖÀ¸¸ç 2024³â¿¡´Â 33.4%ÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Àڱ⠰ø¸í ¿µ»ó(MRI) ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È CAGR 5.4%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
  • ½ÉÀå ¼ö¼ú ºÎ¹®Àº ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç 2024³â¿¡´Â 30.1%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ½Å°æ ¼ö¼ú ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È CAGR 6.0%·Î È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • º´¿ø ºÎ¹®Àº 2024³â 36.0%ÀÇ ÃÖ°íÀÇ ¼öÀÍ Á¡À¯À²·Î ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ ÁöÀ§¸¦ Â÷ÁöÇß½À´Ï´Ù. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ºÎ¹®Àº 2025-2030³â¿¡ °ÉÃÄ °¡Àå ³ôÀº CAGR 5.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ºÏ¹Ì ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº ¼¼°è ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. 2024³â¿¡´Â 36.1%ÀÇ ÃÖ´ë¼öÀÍ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº ¿¹Ãø ±â°£¿¡ °¡Àå ³ôÀº CAGR 6.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅëÀÇ Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

  • Á¦Ç° ½ÃÀå Á¡À¯À²(2024³â ¹× 2030³â)
  • Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, Á¦Ç°º°(2018-2030³â)
  • ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(CT) ½ºÄ³³Ê
  • ÃÊÀ½ÆÄ ½Ã½ºÅÛ
  • Àڱ⠰ø¸í ¿µ»ó(MRI)
  • ³»½Ã°æ
  • X¼± Åõ½Ã °Ë»ç
  • ¾çÀüÀÚ ¹æÃâ ´ÜÃþ ÃÔ¿µ(PET)
  • ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT)

Á¦5Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ¿¬°á ±â¼ú ºñÁî´Ï½º ºÐ¼®

  • ¿¬°á ±â¼ú ½ÃÀå Á¡À¯À²(2024³â ¹× 2030³â)
  • ¿¬°á ±â¼ú ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ¿¬°á ±â¼úº°(2018-2030³â)
  • ½ÉÀå¼ö¼ú
  • ³ú½Å°æ¿Ü°ú
  • Á¤Çü¿Ü°ú
  • ºñ´¢±â°ú
  • ¼ÒÈ­±â³»°ú
  • Á¾¾ç¿Ü°ú
  • ±âŸ

Á¦6Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À²(2024³â ¹× 2030³â)
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ¿¬±¸ ¹× Çмú±â°ü

Á¦7Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â ¹× 2030³â)
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®(2018-2030³â)
  • ºÏ¹Ì
    • ±¹°¡º°(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°(2018-2030³â)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°(2018-2030³â)
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • Âü°¡ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ/»óÀå ±â¾÷
    • Koninklijke Philips NV
    • Medtronic
    • Siemens Healthineers
    • Analogic Corporation
    • GE Healthcare
    • Varian Medical Systems, Inc.
    • Brainlab AG
    • Olympus Corporation
    • Stryker
CSM 25.04.17

Image-guided Therapy Systems Market Growth & Trends:

The global image-guided therapy systems market size is expected to reach USD 6.97 billion by 2030, registering a CAGR of 5.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing geriatric population and increasing cases of chronic diseases are expected to boost the market demand. Other factors propelling the industry growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are driving the industry.

New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Corporation launched ENDO-AID, an AI platform and endoscopy application with computer-aided detection for gastrointestinal applications. The AI platform with an endoscopy system-EVIS X1 enables real-time display. The growing adoption of such advanced systems is expected to drive the industry. The increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on industry growth.

Additionally, many academic institutions are investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute to market expansion. The development of the Image-guided Therapy Program by the Brigham and Women's Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.

Image-guided Therapy Systems Market Report Highlights:

  • The endoscopes segment dominated the global image-guided therapy systems industry and accounted for the largest share of 33.4% in 2024. Magnetic resonance imaging (MRI) is expected to grow at a CAGR of 5.4% over the forecast period.
  • The cardiac surgery segment led the market and accounted for the largest revenue share of 30.1% in 2024. The neurosurgery segment is likely to expand at a lucrative CAGR of 6.0% over the forecast period.
  • The hospitals segment held the dominant position in the market with the highest revenue share of 36.0% in 2024. The ambulatory surgery centers (ASCs) segment is expected to grow at the fastest CAGR of 5.7% from 2025 to 2030.
  • North America image-guided therapy systems market dominated the global market and held the largest revenue share of 36.1% in 2024 and is expected to maintain its lead over the forecast period.
  • Asia Pacific image-guided therapy systems market is projected to exhibit the fastest CAGR of 6.4% over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Connectivity Technology
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Image-Guided Therapy Systems Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Image-Guided Therapy Systems Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Computed Tomography (CT) Scanners
    • 4.4.1. Computed Tomography (CT) Scanners Market, 2018 - 2030 (USD Million)
  • 4.5. Ultrasound Systems
    • 4.5.1. Ultrasound Systems Market, 2018 - 2030 (USD Million)
  • 4.6. Magnetic Resonance Imaging (MRI)
    • 4.6.1. Magnetic Resonance Imaging (MRI)Market, 2018 - 2030 (USD Million)
  • 4.7. Endoscope
    • 4.7.1. Endoscope Market, 2018 - 2030 (USD Million)
  • 4.8. X-ray Fluoroscopy
    • 4.8.1. X-ray Fluoroscopy Market, 2018 - 2030 (USD Million)
  • 4.9. Positron Emission Tomography (PET)
    • 4.9.1. Positron Emission Tomography (PET) Market, 2018 - 2030 (USD Million)
  • 4.10. Single Photon Emission Computed Tomography (SPECT)
    • 4.10.1. Single Photon Emission Computed Tomography (SPECT) Market, 2018 - 2030 (USD Million)

Chapter 5. Image-Guided Therapy Systems Market: Connectivity Technology Business Analysis

  • 5.1. Connectivity Technology Market Share, 2024 & 2030
  • 5.2. Connectivity Technology Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Connectivity Technology, 2018 to 2030 (USD Million)
  • 5.4. Cardiac Surgery
    • 5.4.1. Cardiac Surgery Market, 2018 - 2030 (USD Million)
  • 5.5. Neurosurgery
    • 5.5.1. Neurosurgery Market, 2018 - 2030 (USD Million)
  • 5.6. Orthopedic Surgery
    • 5.6.1. Orthopedic Surgery Market, 2018 - 2030 (USD Million)
  • 5.7. Urology
    • 5.7.1. Urology Market, 2018 - 2030 (USD Million)
  • 5.8. Gastroenterology
    • 5.8.1. Gastroenterology Market, 2018 - 2030 (USD Million)
  • 5.9. Oncology Surgery
    • 5.9.1. Oncology Surgery Market, 2018 - 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Image-Guided Therapy Systems Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Specialty Clinics
    • 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 6.7. Research & Academic Institutes
    • 6.7.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Image-Guided Therapy Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Image-Guided Therapy Systems Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Image-Guided Therapy Systems Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Image-Guided Therapy Systems Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Image-Guided Therapy Systems Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Image-Guided Therapy Systems Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Image-Guided Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Koninklijke Philips N.V.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Medtronic
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Siemens Healthineers
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Analogic Corporation
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. GE Healthcare
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Varian Medical Systems, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Brainlab AG
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Olympus Corporation
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Stryker
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦